ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JULY 2021
Strong sales growth during July; Zinzino group revenue increased with a total of 11%, compared with the previous year
STOCKHOLM, Aug. 5, 2021 /PRNewswire/ -- The revenue in July for Zinzino's sales markets increased by 13% to SEK 96.3 (85.3) million due to strong growth in several regions. Faun Pharma's external sales decreased by 23% and amounted to SEK 3.0 (3.9) million. Overall, the Group increased revenues by 11% to SEK 99.3 (89.2) million compared with the previous year.
Accumulated revenue for January – July 2021 increased by 25% to SEK 755.2 (605.5) million.
Revenues were distributed as follows:
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, firstname.lastname@example.org
Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: email@example.com
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 10:00 the 5th of August 2021.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Company Codes: ISIN:SE0002480442, Stockholm:ZZB
© 2021 PR Newswire. All Rights Reserved.